BROOMFIELD, Colo., May 20, 2025 – PRISM MediaWire – Aclarion, Inc., (“Aclarion” or the “Company”) (Nasdaq: ACON, ACONW), a healthcare technology company that is leveraging
New York, NY, May 20, 2025 – PRISM MediaWire – Creatd, Inc. (OTC: CRTD) has executed a binding Letter of Intent (“LOI”) to acquire 25%
Provides Full-Year Guidance Forecasting Over 100% Revenue Growth; Highlights Enhanced IP and Corporate Valuation HAUPPAUGE, N.Y., May 15, 2025 – PRISM MediaWire – AmpliTech Group,
Record Quarterly Revenue of $5.1 Million Driven by Higher SSi Mantra 3 Unit Sales On Track for July 2025 De Novo Application to the FDA
Company expects its products to be in 30,000 U.S. and Canadian homes by the end of the Second quarter of 2025. Company is Progressing with
MIAMI, May 13, 2025 – PRISM MediaWire – SKYX (NASDAQ: SKYX) (d/b/a “SKYX Technologies”), a highly disruptive advanced and smart home platform technology company for
Meeting the rigorous US regulatory standards required for deployment locally HAUPPAUGE, N.Y., May 12, 2025 – PRISM MediaWire – AmpliTech Group, Inc. (Nasdaq: AMPG, AMPGW),
Company to Provide Corporate Updates Including New Developments, First Quarter 2025 Overview and Financial Results; Conference Call to be Held Wednesday, May 14, 2025, at
BROOMFIELD, Colo., May 12, 2025 – PRISM MediaWire – Aclarion, Inc., (“Aclarion” or the “Company”) (Nasdaq: ACON, ACONW), a healthcare technology company that is leveraging biomarkers and proprietary
[et_pb_section admin_label=”section”][et_pb_row admin_label=”row”][et_pb_column type=”4_4″][et_pb_text admin_label=”Text”] All Clinical Data Validated by Leading Third-Party CRO for Safety, Feasibility and Efficacy FORT LAUDERDALE, Fla., May 08, 2025 –
PRISM MediaWire
info@prismmediawire.com
Phone: 646-780-8850
